Tesla shares trade near $378 amid a heavy investment phase, with Q2 2026 results showing record $28.2 billion revenue and strong deliveries offset by a 57% drop in operating income, negative free cash flow, and automotive gross margins of 16.3% as capital spending exceeds $25 billion annually on AI compute, Optimus humanoid robots, and Cybercab robotaxi development. Market-implied odds reflect trader focus on execution milestones in autonomy and robotics rather than near-term EV profitability, with the stock holding a trailing P/E above 350 despite a 52-week range of $297–$499. The October earnings release around the 28th and any regulatory or production updates on FSD and Optimus represent key near-term catalysts that could shift sentiment.